Biotech sector ponders potential 'bloodbath' (vol 27, pg 3, 2009)

被引：0

作者：

Mitchell, Peter

Huggett, Brady

机构：

来源：

NATURE BIOTECHNOLOGY | 2009年 / 27卷 / 02期

关键词：

D O I：

10.1038/nbt0209-205e

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Nat. Biotechnol. 27, 3–5 (2009); published online 8 January 2009; corrected after print 9 February 2009 In the version of this article initially published, we neglected to define our categories for public biotech firms. In the following definitions, the dollar amounts refer to a firm's market capitalization or 'cap': microcap, <$250 million; small cap, $250 million to <$1 billion; mid-cap, $1 billion to <$5 billion; large cap, ≥$5 billion.

引用

页码：205 / 205

页数：1